C

Cue Biopharma, Inc. (CUE)

NCM – Real Time Price. Currency in USD

27.74

-0.50 (-1.77%)

Market open: Aug 12, 2026, 12:12 PM EDT

29.82

+1.58 (5.61%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Cue Biopharma, Inc. (CUE)

NCM – Real Time Price. Currency in USD

27.74

-0.50 (-1.77%)

Market open: Aug 12, 2026, 12:12 PM EDT

29.82

+1.58 (5.61%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

27M

9M

5M

1M

Cost of goods sold

-348K

-2M

-3M

-2M

Gross Profit

27M

7M

2M

-561K

Operating expenses (excl. COGS)

-54M

-49M

-54M

-53M

Operating Income

-27M

-42M

-52M

-54M

Non-operating income, total

419K

919K

1M

491K

Pretax income

-26M

-41M

-51M

-53M

Equity in earnings

0

Taxes

-500K

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-27M

-41M

-51M

-53M

Discontinued operations

0

Net income

-27M

-41M

-51M

-53M

Dilution adjustment

0

Preferred dividends

0

Search stocks

Cue Biopharma, Inc. (CUE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cue Biopharma, Inc. (CUE)

Income Statement (Annual)